Eris Lifesciences Limited (BOM:540596)
1,624.10
-111.15 (-6.41%)
At close: Jun 20, 2025
Eris Lifesciences Revenue
In the fiscal year ending March 31, 2025, Eris Lifesciences had annual revenue of 28.79B INR with 44.59% growth. Eris Lifesciences had revenue of 7.03B in the quarter ending March 31, 2025, with 28.38% growth.
Revenue
28.79B
Revenue Growth
+44.59%
P/S Ratio
7.69
Revenue / Employee
7.95M
Employees
3,620
Market Cap
221.54B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 28.79B | 8.88B | 44.59% |
Mar 31, 2024 | 19.91B | 3.29B | 19.83% |
Mar 31, 2023 | 16.62B | 3.36B | 25.31% |
Mar 31, 2022 | 13.26B | 1.34B | 11.20% |
Mar 31, 2021 | 11.93B | 1.34B | 12.71% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,646.93B |
HDFC Bank | 2,728.47B |
Tata Consultancy Services | 2,553.24B |
Bharti Airtel | 1,729.85B |
ICICI Bank | 2,006.54B |
State Bank of India | 3,429.39B |
Infosys | 1,647.16B |
Life Insurance Corporation of India | 8,901.58B |